Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

BMJ. 2005 Aug 20;331(7514):439-42. doi: 10.1136/bmj.331.7514.439.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Anticoagulants*
  • Cerebral Hemorrhage / complications*
  • Cerebral Hemorrhage / diagnostic imaging
  • Contraindications
  • Decision Making
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors*
  • Risk Assessment / methods
  • Risk Factors
  • Tomography, X-Ray Computed

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors